2019 Article Archive
Starting this fall, the biggest public high schools in Texas are required to report all sports concussions to a central database as part of one of the nation’s largest statewide endeavors to track brain injuries in youth athletics.
The hormone LEAP2, which naturally blocks the “hunger” hormone ghrelin, is elevated in people with obesity, especially after eating – raising hopes for a treatment that could one day more effectively reduce appetite and, hence, obesity.
An international research consortium including UT Southwestern Emergency Medicine faculty was able to identify what is likely an optimal combination of chest compression frequency and depth when performing CPR.
Manipulating dose, timing of two therapies significantly reduces relapse in mouse models of breast cancer, lung cancer
Changing the standard dose and timing of two therapies greatly cut tumor relapse and reduced side effects in mouse models of kinase mutated breast cancer and lung cancer.
Antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50 percent in patients with a history of liver cancer.
In memoriam: Cell biologist Dr. Woodring Wright made seminal discoveries on aging and cancer development
Dr. Woodring Erik Wright, Professor Emeritus of Cell Biology, passionate educator, and scientific trailblazer in the fight against aging and cancer, died on Aug. 2. He was 70.
Investigators report an innovative strategy for treating advanced kidney cancer.
UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice.
UT Southwestern ranked No. 1 hospital in DFW by U.S. News & World Report, adding to multiple recognitions in 2019
For a third consecutive year, UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth and No. 2 in Texas, according to U.S. News & World Report’s annual Best Hospitals listings released today.
Aggressive methods for reducing high blood sugar following a severe stroke are not more effective than standard, lower risk treatments, according to a new study that offers clarity to a long-debated issue in stroke care.